Previous | Home | EndoTODAY | List | Next
[Endoscopic diagnosis of Borrmann type IV (2) - Fold thickening]
2020-8-10. 8PM. EndoTODAY Live
In depth analysis º¸¸¸ 4Çü ÁøÇ༺ À§¾Ï À§³»½Ã°æ ¾ÆƲ¶ó½º (PDF)
1. DiffuseÇÑ fold thickeningÀÇ ÀüÇüÀûÀÎ À§Ã¼ºÎ º¸¸¸ 4Çü ÁøÇ༺ À§¾Ï
º¸¸¸ 4Çü ÁøÇ༺ À§¾Ï ³»½Ã°æ Áø´ÜÀÇ key´Â Á¡¸·ÁÖ¸§ÀÇ ºñÈÄÀÔ´Ï´Ù. ¾Æ·¡ »çÁøÀ» º¸°í ´À³¦À» Àâ¾Æº¸½Ã±â ¹Ù¶ø´Ï´Ù. ÁÖ¸§ÀÌ ¶Ñ²¨¿öÁö¸é¼ ÁÖ¸§ »çÀÌÀÇ °ñÂ¥±â´Â Á¼¾ÆÁö¸ç, ºñ±³Àû ±æ¸é¼ Âß »¸Àº ´À³¦ÀÌ°í, µÎ²¨¿öÁø ÁÖ¸§ Ç¥¸éÀÇ Á¡¸·º¯È°¡ ÀüüÀûÀ¸·Î À¯»çÇÏ°í (mosaic patternµµ ¸¹À½), °ø±â¸¦ ³Ö¾îµµ Àß ÆìÁöÁö ¾Ê´Â °æ¿ì°¡ ¸¹°í, ȯÀÚ´Â ÃÖ±Ù ¸î °³¿ù »çÀÌ¿¡ early satiety³ª üÁß°¨¼Ò µîÀÇ Áõ»óÀ» °¡Áö°í ÀÖ½À´Ï´Ù.
40´ë ¿©¼º. º¸¸¸ 4Çü Áø´Ü ½Ã ³»½Ã°æ°ú 1³â Àü, 2³â Àü, 3³â Àü »çÁø
F/68. ºñƯÀÌÀû Áõ»ó Á¤µµ¿´´Âµ¥ ¸¶Ä§ °ËÁø ³»½Ã°æ µüÁö°¡ ³¯¶ó¿Í¼ Àα٠°³Àκ´¿ø¿¡¼ °ËÁøÀ» ÇÏ¿© ¹ß°ßµÈ º¸¸¸ 4Çü ÁøÇ༺ À§¾Ï. Initially peritoneal seeding (+)
2. ±¹¼ÒÀûÀÎ À§ÁÖ¸§ ºñÈĸ¦ °¡Áø º¸¸¸ 4Çü ÁøÇ༺ À§¾Ï (À§¾Ï 644)
¹«Áõ»ó ¼ºÀÎÀÇ °ËÁø ³»½Ã°æ¿¡¼ fundus¿¡¼ ÁÖ¸§ÀÌ Âî±ÛÂî±ÛÇÏ°Ô ¹¶ÃÄÀÖ°í µÎ²¨¿öÁø ¼Ò°ßÀÌ ¹ß°ßµÇ¾ú½À´Ï´Ù. ±ÙÁ¢ÇÏ¿© °üÂûÇϸé ÀÛÀº ±Ë¾çµµ ÀÖ¾ú½À´Ï´Ù. Á¶Á÷°Ë»ç¿¡¼ poorly cohesive carcinoma°¡ ³ª¿ÔÀ¸¸é ¼ö¼úÀ» ÇÏ¿´°í º´¸®°ú¿¡¼´Â º¸¸¸ 4ÇüÀ¸·Î ºÐ·ùÇÏ¿´½À´Ï´Ù.
Stomach, radical total gastrectomy: Advanced gastric carcinoma
1. Location : [1] upper third, Center at fundus and posterior wall
2. Gross type : Borrmann type 4
3. Histologic type : tubular adenocarcinoma, poorly (poorly cohesive) differentiated
4. Histologic type by Lauren : diffuse
5. Size : 5x4 cm
6. Depth of invasion : penetrates subserosal connective tissue (pT3)
7. Resection margin: free from carcinoma, safety margin: proximal 2 cm, distal 18 cm
8. Lymph node metastasis : no metastasis in 36 regional lymph nodes (pN0) (0/36: "2", 0/5; "3", 0/2; "4", 0/13; "5", 0/1; "6", 0/2; "7", 0/3; "9", 0/5; "8a", 0/2; "11p", 0/1; "12a", 0/2; "4sb", 0/0; "1", 0/0)
9. Lymphatic invasion : not identified
10. Venous invasion : not identified
11. Perineural invasion : present
12. AJCC stage by 8th edition: pT3 N0
3. À§ ÁÖ¸§ÀÌ ¾ø´Â °÷ÀÇ º¸¸¸ 4Çü ÁøÇ༺ À§¾ÏÀº ¸Å¿ì Áø´ÜÇϱ⠾î·Á¿î Á¾·ùÀÔ´Ï´Ù.
À§ÁÖ¸§ÀÌ ¾ø´Â °÷(À§Ã¼ºÎ ¼Ò¸¸À̳ª Èĺ®)¿¡ º¸¸¸ 4Çü ÁøÇ༺ À§¾ÏÀÌ ¿À¸é fold thickening°ú À¶ÇÕÀÌ ¾øÀÌ À§º®¸¸ µÎ²¨¿öÁö¹Ç·Î Áø´ÜÀÌ ¾î·Á¿ï ¼ö ÀÖ½À´Ï´Ù.
Stomach, subtotal gastrectomy: Advanced gastric carcinoma
1. Location : lower third, Center at body, antrum and lesser curvature
2. Gross type : Borrmann type 4
3. Histologic type : tubular adenocarcinoma, moderately differentiated
4. Histologic type by Lauren : intestinal
5. Size : 8x7.5 cm
6. Depth of invasion : invades serosa (pT4a)
7. Resection margin: free from carcinoma, safety margin: proximal 3 cm, distal 3.3 cm
8. Lymph node metastasis : metastasis to 9 out of 37 regional lymph nodes (pN3a) (perinodal extension: present) (9/37: "3", 4/13; "4", 0/5; "5", 0/0; "6", 0/4; "7", 0/2; "9", 1/3; "8a", 0/1, "11p", 0/0; "12a", 0/3; "4sb", 0/1; "1", 0/0; perigastric LN, 4/5)
9. Lymphatic invasion : present
10. Venous invasion : not identified
11. Perineural invasion : present
12. Peritoneal cytology : negative
13. AJCC stage by 7th edition: pT4a N3a
ÀÚ¼¼ÇÑ ³»¿ëÀº EndoTODAY ºñÈļº À§¿°À» Âü°íÇϽñ⠹ٶø´Ï´Ù. Áõ·Ê »çÁøÀ» ¿Å±é´Ï´Ù.
º¸¸¸ 4Çü ÁøÇ༺ À§¾Ï ÀǽÉÀ¸·Î ÀǷڵǾú´ø 60´ë ¿©¼º. ºñÈļº À§¿°À¸·Î ÆǴܵǾú°í 7³âÀÌ»ó ÃßÀû°üÂû ÇÏ¿´À¸³ª Å« ¹®Á¦°¡ ¾ø¾úÀ½.
À§°¢ºÎ¿¡¼ Á¶±âÀ§¾ÏÀÌ ¹ß°ßµÈ ȯÀÚÀε¥, À§Ã¼ºÎ ÁÖ¸§¿¡¼´Â ºñÈļº À§¿°ÀÇ ¼Ò°ßÀÌ ÀÖ¾úÀ½.
¸¹Àº ºÐµéÀÌ º¸¸¸ 4Çü ÁøÇ༺ À§¾ÏÀ» ÀǽÉÇÏ¿´´ø ºñÈļº À§¿°. Áö³ªÄ¡°Ô ¿ïÅüºÒÅüÇÏ°í ²¿ºÒ²¿ºÒÇÏ¸é º¸¸¸ 4Çü ÁøÇ༺ À§¾ÏÀÇ °¡´É¼ºÀÌ ³·¾ÆÁý´Ï´Ù.^^
°íµîÇлýÀε¥ º¸¸¸ 4Çü ÁøÇ༺ À§¾ÏÀÌ Àǽɵȴٰí ÀÇ·ÚµÊ. ºñÈļº À§¿°À̾úÀ½.
ºñÈļº À§¿°¿¡¼ °£È¤ CT¸¦ ÀÇ·ÚÇϱ⵵ ÇÕ´Ï´Ù. CT¿¡¼ À§º® ÀÚü°¡ ¾Æ´Ï¶ó ÁÖ¸§¸¸ ºñÈÄµÈ °ÍÀ¸·Î °üÂûµÉ ¼ö ÀÖ½À´Ï´Ù.
ºñÈļº À§¿°Àº À§º® ÀÚü°¡ ¾Æ´Ï¶ó ÁÖ¸§¸¸ ºñÈÄµÈ °ÍÀÔ´Ï´Ù. EUS¿¡¼ ÀÌ·¯ÇÑ Æ¯Â¡ÀÌ Àß º¸ÀÌ´Â °æ¿ì°¡ ÀÖ½À´Ï´Ù. (ÁÖÀÇ: º¸ÅëÀº EUS°¡ Å©°Ô µµ¿òµÇÁö ¾Ê½À´Ï´Ù. ³»½Ã°æ ¼Ò°ß ÀÚü°¡ ´õ¿í Áß¿äÇÕ´Ï´Ù.)
[2019-12-11. ¾Öµ¶ÀÚ Áú¹®]
±³¼ö´Ô. EGD ÇÏ´Ùº¸¸é ÁÖ¸§ºñÈÄ ¼Ò°ßÀÌ ½É½ÉÄ¡ ¾Ê°Ô º¸À̴µ¥¿ä. ºñÈÄµÈ ÁÖ¸§À» º¸ÀÏ ¼ö ÀÖ´Â °¢Á¾ º´Àο¡ ´ëÇÑ °¨º°°Ë»ç¸¦ ÇÏ·Á¸é ºñÈÄ ÁÖ¸§ ºÎÀ§¿¡ ´ëÇÑ ¹«ÀÛÀ§ Á¶Á÷°Ë»çµµ ÇÊ¿äÇÒ°Í °°°í Ç︮ÄÚ¹ÚÅÍ °Ë»çµµ ÇÊ¿äÇÒ°Í °°°í stomach CT µµ Âï¾î¾ß µÉ°Í °°Àºµ¥ ¾î´ÀÁ¤µµ ¼±¿¡¼ ÇØ¾ß µÉ±î¿ä? »ç½Ç Àú´Â malignancy°¡ ÀǽɵǴ Á¤µµ°¡ ¾Æ´Ï¸é ±×³É ºñÈļº À§¿°À¸·Î ¸®Æ÷Æ®ÇÏ°í ³Ñ¾î °¬¾ú´Âµ¥ malignancy ÀǽÉÀ» ³»½Ã°æ À°¾È ¼Ò°ßÀ¸·Î¸¸ Çϴ°ÍÀÌ ¸Â´Â°ÇÁöµµ Àß ¸ð¸£°Ú½À´Ï´Ù. ´Ù¸¥ 2Â÷Àû ¿øÀÎ ¾ø´Â ÁÖ¸§ ºñÈÄ°¡ ÀÖÀ»¶§ ±×³É ¸ðÁ¾ÀÇ ¿°Áõ¿¡ ÀÇÇÑ ºñÈļº À§¿°À̶ó°í »ý°¢Çصµ µÇ´Â°ÇÁöµµ ±Ã±ÝÇÕ´Ï´Ù.
[2019-12-11. ÀÌÁØÇà ´äº¯]
¾ÆÁÖ ²ÙºÒ²ÙºÒÇÏ°í ºÒ±ÔÄ¢ÇÑ °æ¿ì´Â Ç︮ÄÚ¹ÚÅÍ¿¡ ÀÇÇÑ ºñÈļº À§¿°ÀÎ °æ¿ì°¡ ¸¹Áö¸¸ ºñ±³Àû ±ÕÀÏÇÏ°Ô Âß µÎ²¨¿öÁø °æ¿ì´Â º¸¸¸ 4ÇüÀ̳ª lymphoma¸¦ ÀǽÉÇÏ´Â °ÍÀÌ ÁÁ½À´Ï´Ù. ƯÈ÷ lymphoma´Â Á¶Á÷°Ë»ç·Î Àß Áø´ÜµÇ´Â ÆíÀÎÁö¶ó... óÀ½ À§ ÁÖ¸§ ºñÈĸ¦ ¹ß°ßÇÏ¸é ²À Á¶Á÷°Ë»ç¸¦ ÇÏ´Â °ÍÀÌ ÁÁ°Ú½À´Ï´Ù.
ÀϺ» °ÔÀÌ¿À ´ëÇÐ µ¿¾Æ½Ã¾Æ ¿¬±¸¼ÒÀå ¼Ò¿¡¾ß ¿ä½ÃÈ÷µ¥ÀÇ ÀÎÅͺä Áß ÀÌ·± ³»¿ëÀÌ ³ª¿Â´Ù ('ÀϺ»Àº Áö±Ý ¹«¾ùÀ» »ý°¢Çϴ°¡?' 52ÂÊ)
"ÀÏ´Ü ¿ë¾î¸¦ ½èÀ¸´Ï, ³»°¡ ÀÌ·¸°Ô ¸»ÇÏ¸é ¹«Ã¥ÀÓÇØ º¸ÀÏÁö ¸ð¸£Áö¸¸, ¹Ìµé ÆÄ¿ö¶ó´Â Á¤ÀÇ ÀÚü°¡ ±×¸® Áß¿äÇÑ °Ç ¾Æ´Ï´Ù. ÀϺ»ÀÇ ¿Ü±³¸¦ ÀÌ·± °üÁ¡¿¡¼ º¸¸é ¾Ë±â ½±´Ù´Â Àǹ̿¡¼ ¾´ ¿ë¾î, Áï ÇϳªÀÇ ÁØ°ÅÁ¡(reference point)À¸·Î ÀÌÇØÇÏ¸é µÉ °ÍÀÌ´Ù. Ã¥¿¡µµ ½èµíÀÌ ¹ÌµéÆÄ¿ö¶ó´Â ¿ë¾î°¡ È¥¶õÀ» ÁØ´Ù¸é ´Ù¸¥ ¿ë¾î·Î ´ëüÇصµ ÁÁ´Ù°í »ý°¢ÇÏÁö¸¸ Á»Ã³·³ ´Ù¸¥ °³³äÀ» ¶°¿Ã¸®±â ¾î·Á¿ü±â ¶§¹®¿¡ ¹ÌµéÆÄ¿ö¶ó´Â Ç¥ÇöÀ» ¾´ °ÍÀÌ´Ù. ¾î·µç ±× '¸»'º¸´Ù´Â ½ÇÁ¦ '³»¿ë'ÀÌ ´õ Áß¿äÇÏ´Ù."
±×·¸´Ù. ÀϺ»ÀÎÀº ´Ü¾î ±× ÀÚüº¸´Ù ³»¿ëÀ» Áß¿äÇÏ°Ô »ý°¢ÇÑ´Ù. ¸»ÇÏ´Â ³»¿ë°ú ±× ¸» ÀÚü°¡ ´Ù¸¥ °æ¿ì°¡ ¸¹´Ù. ÀϺ»ÀεéÀº ÀÌ °£±ØÀ» ºÒÆíÇÏ°Ô ¿©±âÁö ¾Ê´Â´Ù.ÀϺ»ÀÎÀÌ ¸¸µç ÀÇÇпë¾î¿¡µµ °°Àº »ý°¢ÀÌ ´ã°ÜÀÖ´Ù.
¿ì¸®´Â ´Ù¸¥´Ù. ¸» ÀÚü, ´Ü¾î ÀÚü¸¦ Áß¿äÇÏ°Ô »ý°¢ÇÑ´Ù. ´Ü¾î, À̸§À» ´ëÇÑ ÀϺ»Àΰú Çѱ¹ÀÎÀÇ Åµµ´Â ¸Å¿ì ´Ù¸£´Ù. ÀÌ Â÷À̸¦ ÀÌÇØÇÏÁö ¸øÇϸé Å« È¥¶õÀÌ °¡´ÉÇÏ´Ù. ÀϺ»ÀÎÀÇ ÀÔÀå¿¡¼ IIcÇü Á¶±âÀ§¾ÏÀº ÇÔ¸ôµÈ °Í¸¸À» ¸»ÇÏ´Â °ÍÀÌ ¾Æ´Ï´Ù. ±×³É IIcÀÌ´Ù. ±×³É IIc. ÇÔ¸ôÇüÀÌ ¾Æ´Ï´Ù. ±×³É IIc. ´ëÇѹα¹ÀÇ ÀÇ»çµéÀº Àý´ë·Î ÀÌÇØÇÒ ¼ö ¾ø´Â ÀϺ» ¹æ½ÄÀÌ´Ù.
[Home]